-
1
-
-
0035133250
-
Olanzapine: An updated review of its use in the management of schizophrenia
-
Bhana N, Foster RH, Olney R, et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs. 2001;61:111-161.
-
(2001)
Drugs
, vol.61
, pp. 111-161
-
-
Bhana, N.1
Foster, R.H.2
Olney, R.3
-
2
-
-
0031402808
-
Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients
-
Perry PJ, Sanger T, Beasley C. Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients. J Clin Psychopharmacol. 1997;17:472-477.
-
(1997)
J Clin Psychopharmacol
, vol.17
, pp. 472-477
-
-
Perry, P.J.1
Sanger, T.2
Beasley, C.3
-
3
-
-
0035141860
-
Olanzapine plasma concentrations and clinical response: Acute phase results of the North American olanzapine trial
-
Perry PJ, Lund BC, Sanger T, et al. Olanzapine plasma concentrations and clinical response: acute phase results of the North American olanzapine trial. J Clin Psychopharmacol. 2001;21:14-20.
-
(2001)
J Clin Psychopharmacol
, vol.21
, pp. 14-20
-
-
Perry, P.J.1
Lund, B.C.2
Sanger, T.3
-
4
-
-
0034061823
-
Olanzapine concentrations in clinical serum and postmortem blood specimens - When does therapeutic become toxic?
-
Robertson MD, McMullin MM. Olanzapine concentrations in clinical serum and postmortem blood specimens - when does therapeutic become toxic? J Forensic Sci. 2000;45:418-421.
-
(2000)
J Forensic Sci
, vol.45
, pp. 418-421
-
-
Robertson, M.D.1
McMullin, M.M.2
-
5
-
-
4444275473
-
Therapeutic drug monitoring of psychotropic drugs: An outline of the AGNP-TDM expert group consensus guideline
-
Baumann P, Hiemke C, Ulrich S, et al. Therapeutic drug monitoring of psychotropic drugs: An outline of the AGNP-TDM expert group consensus guideline. Ther Drug Monit. 2004;26:167-170.
-
(2004)
Ther Drug Monit
, vol.26
, pp. 167-170
-
-
Baumann, P.1
Hiemke, C.2
Ulrich, S.3
-
6
-
-
0029036027
-
Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection
-
Catlow J, Barton R, Clemens M, et al. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr B. 1995;668:85-90.
-
(1995)
J Chromatogr B
, vol.668
, pp. 85-90
-
-
Catlow, J.1
Barton, R.2
Clemens, M.3
-
7
-
-
0031437166
-
Plasma level monitoring of olanzapine in patients with schizophrenia: Determination by HPLC with electrochemical detection
-
Aravagiri M, Ames D, Wirshing WC, et al. Plasma level monitoring of olanzapine in patients with schizophrenia: determination by HPLC with electrochemical detection. Ther Drug Monit. 1997;19:307-313.
-
(1997)
Ther Drug Monit
, vol.19
, pp. 307-313
-
-
Aravagiri, M.1
Ames, D.2
Wirshing, W.C.3
-
8
-
-
0035808613
-
A sensitive HPLC method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction prodedure
-
Raggi MA, Casamenti G, Mandrioli R, et al. A sensitive HPLC method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction prodedure. J Chromatogr B. 2001;750:137-146.
-
(2001)
J Chromatogr B
, vol.750
, pp. 137-146
-
-
Raggi, M.A.1
Casamenti, G.2
Mandrioli, R.3
-
9
-
-
0031811911
-
Determination of olanzapine in serum by hplc using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs
-
Olesen OV, Linnet K. Determination of olanzapine in serum by hplc using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs. J Chromatogr B. 1998;714:309-315.
-
(1998)
J Chromatogr B
, vol.714
, pp. 309-315
-
-
Olesen, O.V.1
Linnet, K.2
-
10
-
-
0031791989
-
Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry
-
Berna M, Shugert R, Mullen J. Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. J Mass Spectrom. 1998;33:1003-1008.
-
(1998)
J Mass Spectrom
, vol.33
, pp. 1003-1008
-
-
Berna, M.1
Shugert, R.2
Mullen, J.3
-
11
-
-
0345465891
-
Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
-
Bogusz MJ, Kruger KD, Maier RD, et al. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B. 1999;732:257-269.
-
(1999)
J Chromatogr B
, vol.732
, pp. 257-269
-
-
Bogusz, M.J.1
Kruger, K.D.2
Maier, R.D.3
-
12
-
-
0006859013
-
Development of a gas chromatographic method for the determination of olanzapine in human serum, and a report of patient values
-
Xue L, Crookham SB, Diamond FX, et al. Development of a gas chromatographic method for the determination of olanzapine in human serum, and a report of patient values. Clin Chem. 1998;44:A103.
-
(1998)
Clin Chem
, vol.44
-
-
Xue, L.1
Crookham, S.B.2
Diamond, F.X.3
-
16
-
-
3343017171
-
Assessment of storage and transport stability of new antidepressants and antipsychotic drugs for a nationwide TDM service
-
Heller S, Hiemke C, Stroba G, et al. Assessment of storage and transport stability of new antidepressants and antipsychotic drugs for a nationwide TDM service. Ther Drug Monit. 2004;26:459-461.
-
(2004)
Ther Drug Monit
, vol.26
, pp. 459-461
-
-
Heller, S.1
Hiemke, C.2
Stroba, G.3
-
17
-
-
0028938564
-
Megabore capillary gas-liquid chromatographic method with nitrogen-phosphorus selective detection for the assay of haloperidol and reduced haloperidol in serum: Results of therapeutic drug-monitoring during acute therapy of 8 schizophrenics
-
Ulrich S, Meyer FP, Knorr W, et al. Megabore capillary gas-liquid chromatographic method with nitrogen-phosphorus selective detection for the assay of haloperidol and reduced haloperidol in serum: results of therapeutic drug-monitoring during acute therapy of 8 schizophrenics. J Chromatogr B. 1995;663:289-296.
-
(1995)
J Chromatogr B
, vol.663
, pp. 289-296
-
-
Ulrich, S.1
Meyer, F.P.2
Knorr, W.3
-
18
-
-
33644488170
-
Doxepin
-
Müller RK, ed. Berlin: Verlag Gesundheit
-
Müller RK. Doxepin. In: Müller RK, ed. Toxicological Analysis. Berlin: Verlag Gesundheit, 1991:294-296.
-
(1991)
Toxicological Analysis
, pp. 294-296
-
-
Müller, R.K.1
-
20
-
-
0028818912
-
A rapid gas chromatographic method quantitating clozapine in human plasma or serum for the purpose of therapeutic monitoring
-
Jennison TA, Brown P, Crossett J, et al. A rapid gas chromatographic method quantitating clozapine in human plasma or serum for the purpose of therapeutic monitoring. J Anal Toxicol. 1995;19:537-541.
-
(1995)
J Anal Toxicol
, vol.19
, pp. 537-541
-
-
Jennison, T.A.1
Brown, P.2
Crossett, J.3
-
22
-
-
0036337410
-
Therapeutic drug monitoring data of olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
-
Skogh E, Reis M, Dahl ML, et al. Therapeutic drug monitoring data of olanzapine and its N-demethyl metabolite in the naturalistic clinical setting. Ther Drug Monit. 2002;24:518-526.
-
(2002)
Ther Drug Monit
, vol.24
, pp. 518-526
-
-
Skogh, E.1
Reis, M.2
Dahl, M.L.3
-
23
-
-
0037305930
-
Therapeutic drug monitoring of olanzapine: The combined effect of age, gender, smoking and comedication
-
Gex-Fabry M, Balant-Gorgia AE, Balant LP. Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking and comedication. Ther Drug Monit. 2003;25:46-53.
-
(2003)
Ther Drug Monit
, vol.25
, pp. 46-53
-
-
Gex-Fabry, M.1
Balant-Gorgia, A.E.2
Balant, L.P.3
-
24
-
-
0032742782
-
Differential olanzapine plasma concentrations by sex in a fixed-dose study
-
Kelly DL, Conley RR, Tamminga CA. Differential olanzapine plasma concentrations by sex in a fixed-dose study. Schizophren Res. 1999;40:101-104.
-
(1999)
Schizophren Res
, vol.40
, pp. 101-104
-
-
Kelly, D.L.1
Conley, R.R.2
Tamminga, C.A.3
|